- Home
- LMFA vs EDSA Comparison
LMFA vs EDSA Comparison
Compare LMFA & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMFA
- EDSA
- Stock Information
- Founded
- LMFA 2008
- EDSA 2015
- Country
- LMFA United States
- EDSA Canada
- Employees
- LMFA N/A
- EDSA N/A
- Industry
- LMFA Finance: Consumer Services
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- LMFA Finance
- EDSA Health Care
- Exchange
- LMFA Nasdaq
- EDSA Nasdaq
- Market Cap
- LMFA 7.0M
- EDSA 6.2M
- IPO Year
- LMFA 2015
- EDSA N/A
- Fundamental
- Price
- LMFA $1.67
- EDSA $2.04
- Analyst Decision
- LMFA Hold
- EDSA Strong Buy
- Analyst Count
- LMFA 1
- EDSA 1
- Target Price
- LMFA N/A
- EDSA $21.00
- AVG Volume (30 Days)
- LMFA 103.9K
- EDSA 13.8K
- Earning Date
- LMFA 05-15-2025
- EDSA 05-14-2025
- Dividend Yield
- LMFA N/A
- EDSA N/A
- EPS Growth
- LMFA N/A
- EDSA N/A
- EPS
- LMFA N/A
- EDSA N/A
- Revenue
- LMFA $10,555,948.00
- EDSA N/A
- Revenue This Year
- LMFA $0.98
- EDSA N/A
- Revenue Next Year
- LMFA $4.31
- EDSA N/A
- P/E Ratio
- LMFA N/A
- EDSA N/A
- Revenue Growth
- LMFA N/A
- EDSA N/A
- 52 Week Low
- LMFA $1.02
- EDSA $1.55
- 52 Week High
- LMFA $6.11
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- LMFA 48.12
- EDSA 41.50
- Support Level
- LMFA $1.40
- EDSA $1.99
- Resistance Level
- LMFA $2.28
- EDSA $2.14
- Average True Range (ATR)
- LMFA 0.19
- EDSA 0.11
- MACD
- LMFA -0.02
- EDSA -0.03
- Stochastic Oscillator
- LMFA 16.48
- EDSA 34.04
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.